Skip to main content
Clinical Trials/CTRI/2022/04/041901
CTRI/2022/04/041901
Completed
未知

To evaluate the dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types

ITC LIMITED ITC Life Sciences and Technology Centre0 sites23 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ITC LIMITED ITC Life Sciences and Technology Centre
Enrollment
23
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 3, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
ITC LIMITED ITC Life Sciences and Technology Centre

Eligibility Criteria

Inclusion Criteria

  • Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarââ?¬Â¦.)
  • Subjects representing varied skin types (ideally equal representation of all 4 skin types ââ?¬â?? Oily, Normal, Dry and combination) Subjects willing to come for regular follow up and ready to follow instructions during the study period

Exclusion Criteria

  • For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic,Being asthmatic,Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing
  • (whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis

Outcomes

Primary Outcomes

Not specified

Similar Trials